ASTHMANEFRIN Trademark

Trademark Overview

On Tuesday, January 17, 2012, a trademark application was filed for ASTHMANEFRIN with the United States Patent and Trademark Office. The USPTO has given the ASTHMANEFRIN trademark a serial number of 85518098. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, April 21, 2022. This trademark is owned by Nephron Pharmaceuticals Corporation. The ASTHMANEFRIN trademark is filed in the Pharmaceutical Products category with the following description:

Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders
asthmanefrin

General Information

Serial Number85518098
Word MarkASTHMANEFRIN
Filing DateTuesday, January 17, 2012
Status800 - REGISTERED AND RENEWED
Status DateThursday, April 21, 2022
Registration Number4235335
Registration DateTuesday, October 30, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 12, 2012

Trademark Statements

Goods and ServicesInhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders
Pseudo MarkASTHMA NEPHRIN; ASTHMA NEPHRON

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, January 23, 2012
Primary Code005
First Use Anywhere DateThursday, August 30, 2012
First Use In Commerce DateThursday, August 30, 2012

Trademark Owner History

Party NameNephron Pharmaceuticals Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWest Columbia, SC 29172
Party NameNephron Pharmaceuticals Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressOrlando, FL 32811
Party NameNephron Pharmaceuticals Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressOrlando, FL 32811

Trademark Events

Event DateEvent Description
Monday, May 16, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, May 16, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, May 16, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 21, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, April 21, 2022REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, April 21, 2022REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Monday, April 18, 2022TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Tuesday, April 5, 2022POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Tuesday, April 5, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, December 6, 2021TEAS SECTION 8 & 9 RECEIVED
Saturday, October 30, 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, February 16, 2018NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Friday, February 16, 2018REGISTERED - SEC. 8 (6-YR) ACCEPTED
Friday, February 2, 2018TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Thursday, February 1, 2018TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Thursday, January 25, 2018POST REGISTRATION ACTION MAILED - SEC. 8
Wednesday, January 24, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, January 5, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, January 5, 2018TEAS SECTION 8 RECEIVED
Monday, October 30, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, August 13, 2014ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, October 30, 2012REGISTERED-PRINCIPAL REGISTER
Tuesday, September 25, 2012NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, September 24, 2012LAW OFFICE REGISTRATION REVIEW COMPLETED
Saturday, September 22, 2012ASSIGNED TO LIE
Saturday, September 22, 2012ASSIGNED TO LIE
Thursday, September 13, 2012ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, September 13, 2012STATEMENT OF USE PROCESSING COMPLETE
Monday, September 10, 2012USE AMENDMENT FILED
Wednesday, September 12, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, September 10, 2012TEAS STATEMENT OF USE RECEIVED
Tuesday, August 7, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 12, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 12, 2012PUBLISHED FOR OPPOSITION
Wednesday, May 23, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 24, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 24, 2012ASSIGNED TO EXAMINER
Monday, January 23, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, January 20, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

asthmanefrin diseases disorders respiratory treatment pharmaceutical preparations inhaled